Andrx Pharmaceuticals, Inc. v. Biovail Corp

535 U.S. 931, 122 S. Ct. 1305
CourtSupreme Court of the United States
DecidedMarch 18, 2002
Docket01-1050
StatusPublished

This text of 535 U.S. 931 (Andrx Pharmaceuticals, Inc. v. Biovail Corp) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Andrx Pharmaceuticals, Inc. v. Biovail Corp, 535 U.S. 931, 122 S. Ct. 1305 (2002).

Opinion

535 U.S. 931

ANDRX PHARMACEUTICALS, INC.
v.
BIOVAIL CORP.

No. 01-1050.

Supreme Court of the United States.

March 18, 2002.

C. A. D. C. Cir. Certiorari denied. Reported below: 256 F. 3d 799.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
535 U.S. 931, 122 S. Ct. 1305, Counsel Stack Legal Research, https://law.counselstack.com/opinion/andrx-pharmaceuticals-inc-v-biovail-corp-scotus-2002.